BIO-key International, Inc.
BKYI
$4.55
-$0.09-2.03%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -46.38% | -66.43% | 19.59% | 36.95% | 38.36% |
| Total Depreciation and Amortization | -26.11% | -21.01% | -5.19% | 7.02% | 8.40% |
| Total Amortization of Deferred Charges | 39.19% | 44.98% | 75.09% | 82.59% | 78.48% |
| Total Other Non-Cash Items | 2,355.67% | 2,372.52% | -78.94% | -96.67% | -102.07% |
| Change in Net Operating Assets | 30.07% | -145.31% | 77.91% | -167.77% | -117.24% |
| Cash from Operations | -3.58% | -60.21% | 14.71% | -24.25% | -158.15% |
| Capital Expenditure | 53.16% | 8.40% | 110.79% | -496.55% | -444.83% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 53.16% | 8.40% | 110.79% | -496.55% | -444.83% |
| Total Debt Issued | -50.00% | -50.00% | -42.78% | -100.00% | -- |
| Total Debt Repaid | 33.25% | 34.10% | 60.12% | 61.25% | 61.07% |
| Issuance of Common Stock | -45.76% | 248.00% | -39.31% | 35.62% | 35.27% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 49.47% | -168.62% | 59.56% | 27.54% | 27.54% |
| Cash from Financing | -47.82% | 144.52% | -30.59% | 30.10% | 353.38% |
| Foreign Exchange rate Adjustments | -133.30% | -3.41% | -114.66% | -0.91% | -23.42% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -136.25% | 3,158.27% | -84.02% | 46.09% | 7,759.25% |